Lynx Therapeutics, Inc.

Solexa Inc. >>

March 05

Lynx Therapeutics, Inc. and Solexa Ltd combine to become Solexa, Inc.

February 05

Lynx announces funding by the USDA for deep profiling of small rice RNAs by MPSS


November 04

Lynx names Mary L. Schramke acting chief executive officer

October 04

Lynx and Solexa reach OEM development agreement to accelerate development of DNA sequencing instrumentation

University of Delaware awarded U.S. National Science Foundation grant for discovery of small RNA molecules in plants using Lynx MPSS

July 04

Lynx announces publication of a scientific paper showcasing the usefulness of MPSS for whole genome structure analysis

May 04

Lynx announces first quarter financial results

Lynx announces publication of two scientific papers showcasing MPSS(TM) and the posting of plant transcriptome data

March 04

Lynx announces 2003 fourth quarter and full year financial results

Lynx Therapeutics announces workforce reduction

Lynx completes US$4 million private equity financing

January 04

Lynx Therapeutics completes US$4 million private equity financing


November 03

Lynx Therapeutics and the University of Delaware enter into agreement to generate genome-wide gene expression data for rice

Lynx Therapeutics signs multi-year agreement with DuPont


April 02

Lynx and Aventis CropScience to develop a new assay for plant analysis


November 01

Lynx and the University of California, Davis to generate genome-wide plant gene expression data (3955)

January 01

Lynx and Phytera announce partnership to identify genes for biosynthesis of important nutraceutical compounds


June 00

Lynx Therapeutics announces publication of a landmark article (2711)

March 00

Lynx Therapeutics announces renewal of genomics agreement by Aventis CropScience (2603)


December 99

Lynx Therapeutics achieves technical milestone in collaboration with DuPont (2329)

October 99

Lynx Therapeutics announces genomics collaboration with AgrEvo (2159)

April 99

Lynx Therapeutics reports financial results for the first quarter ended March 31, 1999 (N1745)

Lynx Therapeutics announces activation of genomics deal with AgrEvo (N1691)


November 98

DuPont and Lynx Therapeutics announce genomic research collaboration (N1385)
.

Copyright © SeedQuest - All rights reserved